WOLF DALE B
SEC Form 4 insider trading activity
WOLF DALE B has filed 9 SEC Form 4 filings (10 transaction rows) across 3 companies, including AHCO, MOH, EHTH, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, WOLF DALE B is listed as Director at AdaptHealth Corp. Inside the rolling window, WOLF DALE B reported 3 open-market purchases totaling $442K in AHCO and no open-market sales. The largest disclosed transaction in the window is a purchase of 40,000 AHCO shares on Aug 6, 2026, worth $253K.
Companies traded
Other insiders at AHCO
Insider Buying
$442K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has WOLF DALE B made?
WOLF DALE B has filed 9 SEC Form 4 filings (10 transaction rows) across 3 companies, including AHCO, MOH, EHTH since 2025.
Which companies does WOLF DALE B trade?
WOLF DALE B has filed SEC Form 4 disclosures for 3 companies, including AHCO, MOH, EHTH.
When was WOLF DALE B's most recent SEC Form 4 filing?
WOLF DALE B's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is WOLF DALE B's total buy and sell value in the current window?
Inside the rolling retention window, WOLF DALE B bought $442K and sold $0 based on SEC Form 4 filings.
What was WOLF DALE B's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 40,000 AHCO shares on 2026-08-06, worth $253K, per SEC Form 4 filings.